OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA therapeutics: New vaccination and beyond
Huanhuan Wei, Liangliang Zheng, Zefeng Wang
Fundamental Research (2023) Vol. 3, Iss. 5, pp. 749-759
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The dynamic process of mRNA delivery by lipid nanoparticles in vivo
Runpu Ma, Yuting Li, Yi Wei, et al.
Nano Today (2024) Vol. 57, pp. 102325-102325
Closed Access | Times Cited: 10

mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access | Times Cited: 1

Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1497-1497
Open Access | Times Cited: 17

An overview of lipid constituents in lipid nanoparticle mRNA delivery systems
Shiqi Wu, Lixin Lin, Lu Shi, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 8

Engineered mRNA Delivery Systems for Biomedical Applications
Ji Wang, Haofang Zhu, Jingjing Gan, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 14

Principles of lipid nanoparticle design for mRNA delivery
Yiran Zhang, Xinyue Zhang, Yongsheng Gao, et al.
BMEMat (2024)
Open Access | Times Cited: 5

Leveraging high-throughput screening technologies in targeted mRNA delivery
Yuchen Zhang, Zhifei Gao, Xiao Yang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101101-101101
Open Access | Times Cited: 4

Recognition mechanism of RNA by TLR13: Structural insights and implications for immune activation
Yibo Wang, Penghui Li, Hongshuang Wang, et al.
Journal of Molecular Biology (2025), pp. 168988-168988
Closed Access

An efficient mRNA delivery system for genome editing in plants
Fengti Qiu, Chenxiao Xue, Jin‐Xing Liu, et al.
Plant Biotechnology Journal (2025)
Open Access

mRNA therapy: A new frontier in regenerative medicine
Danna Xue, Yue Zhang, Anran Shen, et al.
Deleted Journal (2025)
Open Access

Inhaled non-viral delivery systems for RNA therapeutics
Cheng Huang, Hongjian Li, Xing Duan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access

Reverse engineering high-level resistance to Bt Cry1Ac toxin in Plutella xylostella reveals a hormonal regulatory feedback pathway
Dan Sun, Mingyun Wang, Le Guo, et al.
Pesticide Biochemistry and Physiology (2025), pp. 106382-106382
Closed Access

Enzymatic isolation and microfluidic electrophoresis analysis of residual dsRNA impurities in mRNA vaccines and therapeutics
Adriana Coll De Peña, Matei Vaduva, Nina Li, et al.
The Analyst (2024) Vol. 149, Iss. 5, pp. 1509-1517
Open Access | Times Cited: 3

Current landscape of mRNA technologies and delivery systems for new modality therapeutics
Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P Perez, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 3

ACE mRNA (Additional Chimeric Element incorporated IVT mRNA) for Enhancing Protein Expression by Modulating Immunogenicity
Sora Son, Minsa Park, Jin Kuk Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 2

Lyotropic Liquid Crystalline Phase Nanostructure and Cholesterol Enhance Lipid Nanoparticle Mediated mRNA Transfection in Macrophages
Joshua Iscaro, Haitao Yu, Natalia P. Martínez, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 46
Closed Access | Times Cited: 2

Emerging mRNA Technology for Liver Disease Therapy
Ji Wang, Yile Fang, Zhiqiang Luo, et al.
ACS Nano (2024) Vol. 18, Iss. 27, pp. 17378-17406
Closed Access | Times Cited: 2

Recent Advances in mRNA-Based Therapeutics for Neurodegenerative Diseases and Brain Tumors
Lizhi Yang, Shuo Li, Chao Hou, et al.
Nanoscale (2024)
Closed Access | Times Cited: 2

Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer
Wang Wang, Danni Shan, Guanyi Wang, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100149-100149
Open Access | Times Cited: 1

环形RNA翻译及其在药物研发中的应用
Mouwei Mao, Zheyu Zhang, Huanhuan Wei, et al.
Scientia Sinica Vitae (2024)
Open Access | Times Cited: 1

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, et al.
Annals of Hepatology (2024) Vol. 30, Iss. 1, pp. 101533-101533
Closed Access | Times Cited: 1

Simple Enzymatic Incorporation of 2′OMeU Nucleotide at the End of the Poly-A Tail for Enhancement of the mRNA Stability and Protein Expression
Kazi Morshed Alom, Tasnima Alam, Young Jun Seo
ACS Chemical Biology (2024)
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top